Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Viral Vaccines Market to reach USD 107.58 billion by the end of 2030

Global Viral Vaccines Market Size Study & Forecast, by Form (Liquid, Lyophilized), By Container Format (Vials, Prefilled Syringes), By Biosafety Level Type (Biosafety Level 1, Biosafety Level 2, Biosafety Level 3, Biosafety Level 4), and Regional Analysis, 2023-2030

Product Code: HLSDT-77311496
Publish Date: 10-08-2023
Page: 200

Global Viral Vaccines Market is valued at approximately USD 91.82 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 2.7 % over the forecast period 2023-2030. Viral vaccines are immunizations that are specifically designed to prevent viral infections. They stimulate the immune system to recognize and mount a protective response against specific viral pathogens, reducing the risk of infection or the severity of the disease if infection occurs. The increasing government initiatives to promote vaccination, the increasing development of new products against these diseases, as well as the rising geriatric population are the prominent factors that are spurring the market demand around the world.

The surge in the prevalence of viral diseases is directly influencing the demand for viral vaccines. The global burden of viral diseases, such as influenza, hepatitis, measles, mumps, rubella, and human papillomavirus (HPV), remains significant. The high incidence and impact of these diseases drive the demand for viral vaccines as preventive measures to control their spread and reduce the associated morbidity and mortality. According to the (WHO) article published in 2021 hepatitis B and C account for the majority of viral infections worldwide, with 3 million new cases and 3 million new subjects being reported annually. Thus, these aforementioned factors are propelling the growth of Viral Vaccines Market during the estimated period. Moreover, the technological advancements in vaccine development as well as increasing awareness and vaccination programs present various lucrative opportunities over the forecasting years. However, the limited reimbursement coverage and the high cost associated with the storage and transportation of vaccines are restricting the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Viral Vaccines Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the growing awareness and vaccination programs, rising technological advancements in vaccine development, and expanded vaccination coverage. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The increasing prevalence of viral diseases, rising government initiatives to encourage vaccination, and development of healthcare facilities are significantly propelling the market demand across the region.

Major market players included in this report are:
Seqirus (CSL Limited)
Merck & Co., Inc.
AstraZeneca plc
Emergent BioSolutions Inc.
Novartis, Inc.
GlaxoSmithKline plc
Pfizer, Inc.
Sanofi
Serum institute of India Private Limited
Novavax, Inc.
Recent Developments in the Market:
Ø In November 2022, the U.S. FDA approved GSK’s older adult Respiratory Syncytial Virus (RSV) vaccine candidate for a priority review.
Ø In June 2022, the Canadian government and Bavarian Nordic A/S signed a five-year agreement for the purchase of the IMVAMUNE smallpox vaccine.
Global Viral Vaccines Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Form, Container Format, Biosafety Level Type, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Form:
Liquid
Lyophilized

By Container Format:
Vials
Prefilled Syringes

By Biosafety Level Type:
Biosafety Level 1
Biosafety Level 2
Biosafety Level 3
Biosafety Level 4

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Viral Vaccines Market, by Region, 2020-2030 (USD Billion)
1.2.2. Viral Vaccines Market, by Form, 2020-2030 (USD Billion)
1.2.3. Viral Vaccines Market, by Container Format, 2020-2030 (USD Billion)
1.2.4. Viral Vaccines Market, by Biosafety Level Type, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Viral Vaccines Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Viral Vaccines Market Dynamics
3.1. Viral Vaccines Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing government initiatives to promote vaccination
3.1.1.2. Surge in prevalence of viral diseases
3.1.2. Market Challenges
3.1.2.1. Limited reimbursement coverage
3.1.2.2. High cost associated with storage and transportation of vaccines
3.1.3. Market Opportunities
3.1.3.1. Technological advancements in vaccine development
3.1.3.2. Increasing awareness and vaccination programs
Chapter 4. Global Viral Vaccines Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Viral Vaccines Market, by Form
5.1. Market Snapshot
5.2. Global Viral Vaccines Market by Form, Performance – Potential Analysis
5.3. Global Viral Vaccines Market Estimates & Forecasts by Form 2020-2030 (USD Billion)
5.4. Viral Vaccines Market, Sub Segment Analysis
5.4.1. Liquid
5.4.2. Lyophilized
Chapter 6. Global Viral Vaccines Market, by Container Format
6.1. Market Snapshot
6.2. Global Viral Vaccines Market by Container Format, Performance – Potential Analysis
6.3. Global Viral Vaccines Market Estimates & Forecasts by Container Format 2020-2030 (USD Billion)
6.4. Viral Vaccines Market, Sub Segment Analysis
6.4.1. Vials
6.4.2. Prefilled Syringes
Chapter 7. Global Viral Vaccines Market, by Biosafety Level Type
7.1. Market Snapshot
7.2. Global Viral Vaccines Market by Biosafety Level Type, Performance – Potential Analysis
7.3. Global Viral Vaccines Market Estimates & Forecasts by Biosafety Level Type 2020-2030 (USD Billion)
7.4. Viral Vaccines Market, Sub Segment Analysis
7.4.1. Biosafety Level 1
7.4.2. Biosafety Level 2
7.4.3. Biosafety Level 3
7.4.4. Biosafety Level 4
Chapter 8. Global Viral Vaccines Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Viral Vaccines Market, Regional Market Snapshot
8.4. North America Viral Vaccines Market
8.4.1. U.S. Viral Vaccines Market
8.4.1.1. Form breakdown estimates & forecasts, 2020-2030
8.4.1.2. Container Format breakdown estimates & forecasts, 2020-2030
8.4.1.3. Biosafety Level Type breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Viral Vaccines Market
8.5. Europe Viral Vaccines Market Snapshot
8.5.1. U.K. Viral Vaccines Market
8.5.2. Germany Viral Vaccines Market
8.5.3. France Viral Vaccines Market
8.5.4. Spain Viral Vaccines Market
8.5.5. Italy Viral Vaccines Market
8.5.6. Rest of Europe Viral Vaccines Market
8.6. Asia-Pacific Viral Vaccines Market Snapshot
8.6.1. China Viral Vaccines Market
8.6.2. India Viral Vaccines Market
8.6.3. Japan Viral Vaccines Market
8.6.4. Australia Viral Vaccines Market
8.6.5. South Korea Viral Vaccines Market
8.6.6. Rest of Asia Pacific Viral Vaccines Market
8.7. Latin America Viral Vaccines Market Snapshot
8.7.1. Brazil Viral Vaccines Market
8.7.2. Mexico Viral Vaccines Market
8.8. Middle East & Africa Viral Vaccines Market
8.8.1. Saudi Arabia Viral Vaccines Market
8.8.2. South Africa Viral Vaccines Market
8.8.3. Rest of Middle East & Africa Viral Vaccines Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Seqirus (CSL Limited)
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Merck & Co., Inc.
9.3.3. AstraZeneca plc
9.3.4. Emergent BioSolutions Inc.
9.3.5. Novartis, Inc.
9.3.6. GlaxoSmithKline plc
9.3.7. Pfizer, Inc.
9.3.8. Sanofi
9.3.9. Serum institute of India Private Limited
9.3.10. Novavax, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now